Allspring Global Investments Holdings LLC reduced its holdings in Chemed Co. (NYSE:CHE – free report ) by 32.1% during the first quarter, according to its latest 13F filing with the SEC. It sold 396 shares during the period, giving it a holding of 837 shares of the company. Allspring Global Investments Holdings LLC’s holdings in Chemed were worth $537,000 at the end of the most recent quarter.
Other hedge funds and institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in Chemed by 9.2% in the third quarter. JPMorgan Chase & Co. now owns 287,386 shares of the company’s stock valued at $149,355,000 after purchasing an additional 24,161 shares during the period. Toroso Investments LLC increased its holdings in Chemed by 13.7% in the third quarter. Toroso Investments LLC now owns 1,991 shares of the company’s stock valued at $1,035,000 after purchasing an additional 240 shares during the period. Silver Oak Securities Incorporated acquired a new stake in Chemed worth $126,000 in the third quarter. Wellington Management Group LLP increased its holdings in Chemed by 0.3% in the third quarter. Wellington Management Group LLP now holds 386,237 shares of the company’s stock valued at $200,727,000 after purchasing an additional 1,044 shares during the period. Finally, Kentucky Teachers Retirement System increased its stake in Chemed by 94.3% in the third quarter. Kentucky Teachers Retirement System now holds 5,103 shares of the company’s stock valued at $2,652,000 after purchasing an additional 2,477 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Internal activities at Chemed
In related news, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction value of $153,638.32. Following the sale, the director now owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The sale was disclosed in a filing with the SEC, which can be accessed on the SEC’s website. In related news, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction value of $153,638.32. Following the sale, the director now owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The sale was disclosed in a filing with the SEC, which can be accessed on the SEC’s website. Also, CEO Kevin J. McNamara sold 1,500 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the CEO now directly owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Insiders sold a total of 5,784 shares of the company’s stock during the quarter, for a total value of $3,240,053. 3.32% of the stock is owned by company insiders.
Analyst Rating Changes
CHE has been the topic of many analyst reports recently. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Royal Bank of Canada lowered their target price on Chemed from $712.00 to $697.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 21st.
Check out CHE’s latest stock report
Chemed trading down 1.2%
On Wednesday, Chemed’s shares opened trading at $527.82. The company has a market cap of $7.99 billion, a P/E ratio of 28.41, a P/G ratio of 2.22 and a beta of 0.43. Chemed’s 12-month low is $492.84 and high is $654.62. The stock’s 50-day moving average price is $550.41 and its 200-day moving average price is $586.81.
Chemed (NYSE:CHE – get free report ) released its quarterly earnings report on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). The company’s revenue for the quarter was $589.23 million, missing the analyst estimate of $587.18 million. Chemed had net margins of 12.36% and return on equity of 30.52%. Analysts expect Chemed to post earnings of $21.54 per share for the year.
Chemed Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were paid a dividend of $0.40 per share. This equates to a dividend of $1.60 on an annualized basis and a yield of 0.30%. The ex-dividend date was Thursday, May 30th. Chemed’s dividend payout ratio is currently 8.61%.
Chemed Company Profile
(Free report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home care aides, social workers, clergy and volunteers primarily in the United States. The company operates through its VITAS and Roto-Rooter divisions. The company provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers through company-owned branches, independent contractors and franchises.
Recommended articles
Receive Chemed Daily news and reviews –Enter your email address below to receive a concise summary of the latest news and analyst ratings on Chemed and related companies every day with MarketBeat.com’s free email newsletter.
